Canaccord bullish on Trupanion stock as pet acquisition spend ramps up

On Friday, Canaccord Genuity maintained a positive outlook on Trupanion, Inc. (NASDAQ:TRUP), reiterating a Buy rating and a $50.00 price target for the stock. The firm's stance was supported by insights from the 2024 Shareholder Meeting which highlighted Trupanion's strategies and performance metrics.

The company's focus areas such as increased spending on pet acquisition, international growth plans, conversion trends, competitive landscape changes, and the development of non-core products were key discussion points at the meeting. Trupanion has reported an increase in subscription enrolled pets, reaching approximately 1.029 million as of August 31, up from around 1.021 million at the end of the second quarter. This growth aligns with Canaccord's third-quarter estimate of 1.034 million.

Management at Trupanion has reaffirmed their goal to achieve a 15% subscription adjusted operating income (AOI) margin by the fourth quarter of 2024. The company's gradual improvement in margins is facilitating a more aggressive approach towards pet acquisition spending, which is expected to yield significant results starting in the first quarter of 2025.

Despite a forecasted year-over-year growth deceleration of four percentage points in subscription revenue, the recent rate approvals in two major markets, California and New York, are not fully reflected in current consensus estimates. This oversight suggests that there could be potential for future upward adjustments in the fiscal year 2025 and beyond.

In other recent news, Trupanion, a provider of medical insurance for pets, has experienced significant developments. BofA Securities has expressed positive projections for the company, expecting stronger margins by 2025 due to ongoing price increases. This optimistic outlook follows Trupanion's investor day event and is based on the firm's belief that the company is poised for substantial earnings growth.

In terms of personnel, Trupanion has appointed John Gallagher as its new Chief Operating Officer (COO), with a compensation package that includes an increased base salary, a bonus target, and restricted stock units. Gallagher, having been with the company since 2016, is expected to lead the North American growth teams and continue his oversight of operational support teams.

On the financial front, Trupanion reported a 16% year-over-year increase in Q2 revenue, reaching $314.8 million. Subscription revenue contributed significantly to this growth, amounting to $208.6 million, despite a 15% decrease in new pet acquisitions. The company has also updated its full-year revenue guidance to $1.263 billion - $1.279 billion, reflecting its confidence in continued growth.

These recent developments highlight Trupanion's commitment to growth and operational excellence, despite challenges such as higher operating expenses and a decrease in new pet acquisitions. The company's efforts are backed by BofA Securities' positive outlook and the expectation of a more favorable medical loss ratio in the coming years.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.